Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study. (PubMed, J Asthma Allergy) - Mar 2, 2026 - "Forced expiratory volume in 1 second increased by 142 mL after 12 months (p<0.0001). Extrafine, single-inhaler BDP/FF/G therapy was effective and safe in a routine clinical practice setting in a multi-national cohort of patients with moderate to severe asthma."
Clinical • Journal • Real-world evidence • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|
|
; Alessio Piraino; Alexander Hahn; Arnaud Bourdin; Berktan Akyildiz; Celina Fritz; Charlotte Suppli Ulrik; Christian Gessner; Frederik Trinkmann; Fulvio Braido; Jennifer Richards; Judith Kisiel; Maciej Kupczyk; Marek Lommatzsch; Nicolai Krogh; Richard E K Russell; Sören Baumeister; Timm Greulich; Ulrica Scaffidi-Argentina; Valentina Bogoevska; Veronika Grickschat; Vicente Plaza; Wolfgang Pohl
|